Lupin Q2 results: Net profit falls 22% to ₹1,155 cr, revenue at ₹7,827 cr
Executive Brief • Key Highlights
Fast factual intelligence distilled for busy investors, executives, and answer bots:
- ✓Lupin reported a 22 per cent drop in net profit to ₹1,155 crore for the September quarter on Wednesday.
- ✓Revenue grew to ₹7,827 crore, but an exceptional item impacted earnings.
- ✓Managing Director Nilesh Gupta said, "We delivered a strong first half of FY27, underpinned by solid growth across key markets."
Story at a Glance
- Category
- MARKET
- Reported By
- Business Standard
- Reading Speed
- 3 Minute(s)
- Market Focus
- India Economy
Homegrown pharma major Lupin on Wednesday posted a 22.19 per cent decline in consolidated net profit to ₹1,155.30 crore in the September quarter, dragged down by an exceptional item.
The company had posted a net profit of ₹1,484.83 crore in the corresponding period of the previous fiscal year, it said in a regulatory filing to the exchanges.
Revenue from operations was ₹7,827.26 crore during the quarter under review, up from ₹7,047.51 crore in the year-ago period, it said.
Lupin's total expenses also rose to ₹6,374.46 crore during the quarter from ₹5,130.54 crore in the same period last year.
During the April-September period in FY27, Lupin's net profit declined 4.95 per cent to ₹2,572.28 crore from ₹2,706.29 crore a year earlier, the filing said.
Unlock the Full Story with ArthNow Premium
To continue reading this complete financial story and in-depth market context, upgrade to ArthNow Premium. Enjoy unlimited access across Web and Mobile.
Business Standard
Read the full, original unfiltered story directly on the publisher's portal.